Viemed Healthcare (NASDAQ:VMD) Downgraded to “Hold” Rating by Freedom Capital

Viemed Healthcare (NASDAQ:VMD) was downgraded by analysts at Freedom Capital from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Separately, Weiss Ratings raised Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Viemed Healthcare has a consensus rating of “Hold”.

Viemed Healthcare Trading Down 3.1%

Shares of VMD opened at $9.52 on Wednesday. The stock’s 50-day moving average is $11.15 and its two-hundred day moving average is $9.75. The stock has a market cap of $362.62 million, a PE ratio of 26.45 and a beta of 1.10. Viemed Healthcare has a 12 month low of $6.05 and a 12 month high of $12.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.10.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a return on equity of 10.16% and a net margin of 4.81%.The company had revenue of $78.10 million during the quarter, compared to analysts’ expectations of $78.00 million. Equities analysts forecast that Viemed Healthcare will post 0.44 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Viemed Healthcare news, Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares in the company, valued at $868,457. The trade was a 20.94% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider William Frazier sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. The trade was a 12.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 20.60% of the stock is currently owned by company insiders.

Institutional Trading of Viemed Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of VMD. North Star Investment Management Corp. acquired a new stake in shares of Viemed Healthcare in the 1st quarter valued at about $921,000. Arrowstreet Capital Limited Partnership grew its stake in Viemed Healthcare by 101.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after purchasing an additional 358,863 shares in the last quarter. Hillsdale Investment Management Inc. acquired a new stake in Viemed Healthcare during the first quarter valued at approximately $1,834,000. Lazard Asset Management LLC raised its stake in Viemed Healthcare by 117.6% during the first quarter. Lazard Asset Management LLC now owns 215,938 shares of the company’s stock valued at $1,989,000 after buying an additional 116,700 shares in the last quarter. Finally, Expect Equity LLC lifted its holdings in Viemed Healthcare by 59.6% during the 4th quarter. Expect Equity LLC now owns 173,970 shares of the company’s stock worth $1,293,000 after buying an additional 64,961 shares during the last quarter. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.